Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Central Excise Central Excise + AT Central Excise - 2023 (11) TMI AT This

  • Login
  • Cases Cited
  • Referred In
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2023 (11) TMI 718 - AT - Central Excise


Issues involved: Classification of the product 'Salmonella Antigens' u/s Central Excise Tariff 3822 or 3002.

Details of the Judgment:

Issue 1: Classification of the product under Central Excise Tariff 3822 or 3002

The appellant argued that the issue had already been settled in their favor in a previous Tribunal order dated 17.10.2013. The Tribunal referred to the earlier order dated 03.10.2011, where it was established that the product 'Widal-Salmonella Antigen Kit' should be classified under Chapter heading 30.02. The Tribunal highlighted that the product in question falls under Chapter heading No. 30.02 based on the essential character of the kit, as described in the HSN Notes. The Tribunal also cited the apex court's ruling in the Span Diagnostics case, emphasizing that 'antisera' falls under Chapter Heading 30.02. Therefore, the product 'Widal-Salmonella Antigen Kit' was correctly classified under Chapter heading 30.02. The Tribunal concluded that the issue was no longer res-integra based on the previous decisions and allowed the appeal, setting aside the impugned order.

In conclusion, the Appellate Tribunal CESTAT AHMEDABAD ruled in favor of the appellant, holding that the product 'Salmonella Antigens' should be classified under Central Excise Tariff 3002 based on the precedent set in previous orders and the interpretation of relevant legal provisions and case law.

 

 

 

 

Quick Updates:Latest Updates